Fieldpoint Private Securities, LLC Supernus Pharmaceuticals, Inc. Transaction History

Fieldpoint Private Securities, LLC

0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$25.33 - $34.25 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	SELL	$25.47 - $33.37 $59,956 - $78,552	-2,354 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$29.96 - $38.87 $70,525 - $91,499	2,354 New	2,354 $78,000
Q4 2017 Feb 15, 2018	SELL	$36.4 - $42.6 $63,772 - $74,635	-1,752 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$36.75 - $49.65 $64,386 - $86,986	1,752	1,752 $70,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.